Pharmacological models of parkinson's disease in rodents

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)


Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Despite the substantial progress that has been achieved, the precise mechanisms involved in the development of this disease are still not fully understood. The most common concepts relate to the genetic background and environmental/toxic effects. A number of model systems have been introduced, which mimic the human disease to varying extents. In this chapter, we introduce some of the most widely accepted protocols of the pharmacological models of Parkinson's disease.

Original languageEnglish
Title of host publicationNeurodegeneration
Subtitle of host publicationMethods and Protocols
EditorsGiovanni Manfredi, Hibiki Kawamata
Number of pages17
Publication statusPublished - Oct 24 2011

Publication series

NameMethods in Molecular Biology
ISSN (Print)1064-3745



  • Genetic models
  • Parkinson's disease
  • Toxin models

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Klivenyi, P., & Vecsei, L. (2011). Pharmacological models of parkinson's disease in rodents. In G. Manfredi, & H. Kawamata (Eds.), Neurodegeneration: Methods and Protocols (pp. 211-227). (Methods in Molecular Biology; Vol. 793).